Adeno, Mamma, Prostata, Pankreas, stomach, Ovarial, Endometriumca, Sarkom, Basaliom, lymphoma, Histiocytom

For further Mali gnomes today Tallbergs codes are to us at the disposal. Except the respective amino acids ** and minerals *** are used further Therapeutika:
Amino acid code
Trace elements (different depending upon kind of tumor)
Physiological doses of Vit. A, B, D, D, E, partly Folsäure in mg doses
Neurolipide
Tumorvakzine ****
special laboratory diagnostics ***** (e.g. hormone status to process control)
partly inoculation against influenza A B I would like to present some important Mal gnome forms briefly:Prostata approx.:The following bio immune components are used:
Arginin, Asparagin, Glutamin, Glycin, Lysin, Serin

Summary from “bio immune therapy Dr. med. Martin Landenberger 08.2005”

5) Gerson, Max: Eine Krebstherapie, 50 geheilte Fälle, Verlag Waldthausen, ISBN 3-8) Tallberg, Thomas, Deutsche Zeitschrift für Onkologie, 2003; 35: 78-999) Kremer, Heinrich, Die stille Revolution der Krebs- und AIDS-Medizin13) Tallberg, Th., Mahlberg, K., Kalima, T., Experimental and clinical studies on cancer immunotherapy. In: Present Status of Non-Toxic Concepts in Cancer. Eds.K.-F. Klippel & E. Maher. Proc Int Symp Nonwieler/Trier, April 1986, Karger,Basel, 1987, 237- 263.17) Tallberg, Th.: Biological food supplementation combined with specific autologous cancer immuno-therapy in patients suffering from renal carcinoma or malignant melanoma. NAFAS Sci 6 (2001) 3- 17.18) Tallberg, Th., Kalima, T., Hattunen, P., Tykkä, H., Mahlberg, K., Matous, B., Sundell, B.: Postoperative active specific immunotherapy with supportive measures in patients suffering from recurrent metastasized melanoma. J Surg Oncol 33 (1986) 115- 119.19) Tallber, Th., Uusitalo, R., Sarna, S., Seregard, S., Werschnik, C.: Improvement of the recurrence-free interval using biological adjuvant therapy in uveal melanoma. Anticancer Res. 20 (2000) 1969- 1976.21) Tallberg, Th., Tykkä, H., Mahlberg, K., Halttunen, P., Lehtonen, T., Kalima, T., Sarna, S.: Active specific immunotherapie with supportive measures in the treatment of palliatively nephrectomized, renal adenocarcinoma patients. Eur Urol 11 (1985) 233- 243.22) Tallberg, Th., Matous, B., Tykkä, H., Vosmik, Fr., Sarna, S., Bauer, J., Krajsova, I., Sundell, B.: Malignent melanoma. Effect of postoperative specific immunotherapy and dietary supplementation on progress and prognosis. Tumor Diagn U Ther 12 (1991) 139- 146.23) Brillinger, G.-U.: Aktive Patienten-Spezifische Immunterapie (APSI) zur Tumorbehandlung, Krebsforum, 23 / 03 (1992)24) Tallberg, Th., Stenbäck, H., Hallamaa, R., Dabek, J., Johansson, E., Kallio, E.: Studies on the mitochondrial regulation of the genome. Dtsch Zschr Oncol 34 (2002) 128- 139.25) Tallberg, Th., Kinnunen, R.E., Stenbäck, H., Virtanen, I., Palkama, A.: Bioimmuntherapie of equine sarcoid with specific reference to intracellular histopathological reactions. Dtsch Zschr Oncol 27 (1995) 157- 163.26) Tallberg, Th., Stenbäck, H., Dabek, J., Palkama, A.: Complete disappearance of human malignant histiocytoma cells following dietary biotherapy, leading to activation of inductional control mediated by mitochondria. J Aust Coll Nutr & Env Med 15(2) (1996) 5- 10.